Where does Karl Storz Endovision, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Karl Storz Endovision, Inc. ranks #10,978 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Karl Storz Endovision, Inc. hold?

Karl Storz Endovision, Inc. holds 28 US utility patents granted between 2015 and 2025, spanning 9 technology areas.

What is Karl Storz Endovision, Inc.'s Innovation Score?

Karl Storz Endovision, Inc. has an Innovation Score of 34.4 out of 100 (47th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Karl Storz Endovision, Inc. focus on?

Karl Storz Endovision, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 23 patents, ranking #784 of 7,127 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is Karl Storz Endovision, Inc.'s patent grant rate increasing or decreasing?

Karl Storz Endovision, Inc.'s recent grant velocity is -20% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Karl Storz Endovision, Inc.'s patents?

Karl Storz Endovision, Inc.'s patents average 16.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Karl Storz Endovision, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Karl Storz Endovision, Inc.

USPTO PatentsView assignee record - 28 granted patents across 9 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Karl ranks #10,978 of 49,997 tracked US assignees by granted-patent volume, with 28 patents across 9 technology areas.

#10,978
of 49,997 US assignees by volume: 47th percentile
by Innovation Score (34.4/100): 16.3
avg claims per patent: -20%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10978 · US Corporation #10,978 · 28 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 28 grants
UPPER-Q #10,978/49,997
PHOTO-FINISH Jiangsu Academy of…
CPC-NARROW A61B · 9 areas
INNOV-THIN 34.4/100
CLAIMS-RICH 16.3 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -20% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Jiangsu Academy of Agricultural Sciences (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Karl’s 34.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.6 pts (34%) Velocity 2.4 pts (7%) Breadth 10.6 pts (31%) Claim depth 9.8 pts (28%)

Qualcomm Incorporated · highest

85
Karl Storz Endovision · this assignee

34
Nyxoah · near

34
Royal Group · near

34
Tricam Industries · near

34
Vaxiion Therapeutics · near

34
3D Lighting… · lowest

7

What this shows Karl's Innovation Score is 34.4/100 (47th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Karl?

Each dot is one of Karl’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Karl’s own 16.3 claims/patent is ABOVE the 7.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Karl vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Karl's grants concentrate

Karl Storz Endovision, Inc. is a focused PatentsView assignee: 9 CPC subclasses with 82.1% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2019 (7 grants) versus a trough of 1 in 2017. By volume, Karl sits between JLG Industries, Inc. and Lucid Software Inc..

Karl's three-year grant acceleration

Karl Storz Endovision, Inc. shows 5 grants in 2022–2024 against only 14 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

JLG Industries

28
Jiangsu Academy o…

28
K4connect

28
Kaijo

28
KAZ Europe SÀRL

28
Kocher-plastik Ma…

28
Kingsway Enterpri…

28
Lucid Software

28
Karl Storz Endovi… ◀

28

What this shows Karl holds 28 patents at rank #10,976, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Karl

By rank, the assignees closest to #10,976 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Karl's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Karl, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Karl ranks #784 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (34 here).

Tricam Industries, LLC 34 Royal Group, Inc. 34 Nyxoah SA 34 Vaxiion Therapeutics, LLC 34

Karl's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 47th percentile higher than 47% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Karl Storz Endovision, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	7.1%
2016	5	17.9%
2017	1	3.6%
2019	7	25.0%
2020	5	17.9%
2021	2	7.1%
2022	3	10.7%
2023	1	3.6%
2024	1	3.6%
2025partial year	1	3.6%

Which technologies does Karl Storz Endovision, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 23

G02B - Optical Elements, Systems OR Apparatus 10

H04N - Pictorial Communication, e.g. Television 6

G01J - Measurement OF Intensity, Velocity, Spectral Content, Polarisation, Phase OR Pulse Characteristics OF Infrared, Visible OR Ultraviolet LIGHT; COLORIMETRY; Radiation Pyrometry 2

G01L - Measuring Force, Stress, Torque, Work, Mechanical Power, Mechanical Efficiency, OR Fluid Pressure 1

G01M - Testing Static OR Dynamic Balance OF Machines OR STRUCTURES; Testing OF Structures OR Apparatus, NOT Otherwise Provided FOR 1

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

H05K - Printed CIRCUITS; Casings OR Constructional Details OF Electric APPARATUS; Manufacture OF Assemblages OF Electrical Components 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Karl Storz Endovision, Inc.'s patent record in context - here's where to go next.

Karl Storz Endovision, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 82.1% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #10,978 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Karl Storz Endovision, Inc. against JLG Industries, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.